Avsola infliximab-axxq 100 mg lyophilized powder for injection Images
Generic Name: infliximab
This medication has been identified as Avsola infliximab-axxq 100 mg lyophilized powder for injection. It is supplied by Amgen Inc.
Avsola is used in the treatment of Ankylosing Spondylitis; Crohn's Disease; Crohn's Disease, Active; Inflammatory Bowel Disease; Plaque Psoriasis and belongs to the drug class TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Avsola infliximab-axxq 100 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Avsola
- Generic Name
- infliximab
- Strength
- infliximab-axxq 100 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- TNF alfa inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- National Drug Code (NDC)
- 55513-0670
More about Avsola (infliximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
- En español
Patient resources
- Avsola drug information
- AVSOLA (Infliximab Intravenous) (Advanced Reading)
- AVSOLA (Infliximab-axxq Intravenous) (Advanced Reading)
Other brands
Remicade, Inflectra, Renflexis, Ixifi, Zymfentra
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.